Workflow
科创板打新
icon
Search documents
科创板打新来了:屹唐股份明日申购
屹唐股份明日开启申购,公司本次发行前总股本为26.60亿股,本次拟公开发行股票2.96亿股,占发行后 总股本的比例为10.00%,其中网上发行4137.80万股,申购代码787729,申购价格为8.45元 ,发行市盈 率为51.55倍,单一账户申购上限为4.10万股,申购数量为500股的整数倍,顶格申购需持有沪市市值 41.00万元。 2、参与证券交易24个月以上; 主要财务指标 | 财务指标/时间 | 2024年 | 2023年 | 2022年 | | --- | --- | --- | --- | | 总资产(万元) | 995291.53 | 834107.59 | 759881.12 | | 净资产(万元) | 591472.32 | 534314.25 | 498059.99 | | 营业收入(万元) | 463297.78 | 393142.70 | 476262.74 | | 归属母公司股东的净利润(万元) | 54080.21 | 30941.93 | 38252.22 | | 基本每股收益(元) | 0.2000 | 0.1200 | 0.1400 | | 稀释每股收益(元) | 0.200 ...
影石创新今日申购 6.50万市值可顶格申购
Company Overview - YingShi Innovation has initiated its public offering, with a total share capital of 360 million shares before the issuance and plans to issue 41 million shares, accounting for 10.22% of the post-issue total share capital [1] - The company focuses on the research, production, and sales of smart imaging devices such as panoramic cameras and action cameras [1] IPO Details - The subscription code for the public offering is 787775, with a subscription price set at 47.27 yuan per share and an issuance price-to-earnings ratio of 20.04 times [1] - The maximum subscription limit for a single account is 6,500 shares, requiring a minimum market value of 65,000 yuan in the Shanghai stock market for top-tier subscriptions [1] - The online issuance quantity is 6.56 million shares, with the total issuance quantity being 41 million shares [1] - The announcement of the winning numbers and payment date is scheduled for June 4, 2025 [1] Fundraising Allocation - The company plans to allocate 195.43 million yuan for the construction of a smart imaging device production base [1] - An additional 268.34 million yuan is designated for the establishment of a research and development center in Shenzhen [1] Financial Performance - Total assets for 2024 are reported at 502,081.23 million yuan, a significant increase from 304,651.82 million yuan in 2023 and 198,008.31 million yuan in 2022 [2] - Net assets have risen to 318,107.45 million yuan in 2024 from 218,580.99 million yuan in 2023 and 136,961.29 million yuan in 2022 [2] - Operating revenue for 2024 is 557,412.56 million yuan, up from 363,639.23 million yuan in 2023 and 204,113.36 million yuan in 2022 [2] - The net profit attributable to shareholders of the parent company for 2024 is 99,474.91 million yuan, compared to 82,957.51 million yuan in 2023 and 40,733.40 million yuan in 2022 [2] - Basic earnings per share for 2024 stand at 2.76 yuan, an increase from 2.30 yuan in 2023 and 1.13 yuan in 2022 [2] Research and Development - Research and development expenses for 2024 amount to 77,658.91 million yuan, compared to 44,768.03 million yuan in 2023 and 25,601.32 million yuan in 2022 [3] - The ratio of research and development expenses to operating revenue is 13.93% for 2024, up from 12.31% in 2023 and 12.54% in 2022 [3]
汉邦科技明日申购 5.00万市值可顶格申购
Company Overview - Hanbang Technology is a high-tech enterprise focused on chromatography technology, providing professional separation and purification equipment, consumables, application technology services, and related technical solutions primarily for the pharmaceutical and life sciences sectors [1]. IPO Details - The company is set to launch its public offering with a total share capital of 66 million shares, of which 22 million shares will be publicly issued, representing 25% of the post-issue total share capital [1]. - The issue price is set at 22.77 yuan per share, with an earnings per share (EPS) ratio of 26.35 times, compared to the industry average of 28.04 times [1]. - The maximum subscription limit for a single account is 5,000 shares, requiring a minimum market value of 50,000 yuan in the Shanghai market for top-tier subscriptions [1]. Fundraising Allocation - The funds raised will be allocated to several projects, including: - Production project for 1,000 units of liquid chromatography series separation equipment (193.03 million yuan) - Construction of a chromatography separation equipment R&D center (271.10 million yuan) - Production project for 2,000 units of laboratory chromatography separation and purification instruments (224.76 million yuan) - Supplementing working capital (291.11 million yuan) [1]. Financial Performance - Key financial indicators for Hanbang Technology include: - Total assets for 2024 are projected at 1.32 billion yuan, a decrease from 1.35 billion yuan in 2023 and 1.40 billion yuan in 2022 [1]. - Net assets have increased to 739.63 million yuan in 2024 from 638.37 million yuan in 2023 and 566.92 million yuan in 2022 [1]. - Operating revenue is expected to reach 690.88 million yuan in 2024, up from 619.01 million yuan in 2023 and 481.79 million yuan in 2022 [1]. - Net profit attributable to shareholders is projected at 79.34 million yuan for 2024, compared to 51.50 million yuan in 2023 and 38.56 million yuan in 2022 [1]. - Basic and diluted earnings per share are both expected to be 1.20 yuan in 2024, up from 0.78 yuan in 2023 and 0.62 yuan in 2022 [1]. - The weighted average return on equity is projected at 11.51% for 2024, an increase from 8.55% in 2023 and 9.86% in 2022 [1]. - Net cash flow from operating activities is expected to be 129.88 million yuan in 2024, compared to 113.33 million yuan in 2023 and 19.84 million yuan in 2022 [1]. - R&D investment is projected at 41.85 million yuan in 2024, representing 6.06% of operating revenue, consistent with previous years [1].